Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Antibiotic resistance: the emergence of plasmid-mediated colistin resistance enhances the need of a proactive one-health approach.

Piffaretti JC.

FEMS Microbiol Lett. 2016 Mar;363(5):fnw034. doi: 10.1093/femsle/fnw034. Epub 2016 Feb 11. No abstract available.

PMID:
26872493
2.

Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group.

Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F, Zucca E.

Hematol Oncol. 2012 Sep;30(3):137-42. doi: 10.1002/hon.1015. Epub 2011 Nov 21.

PMID:
22105737
3.

Global distribution and epidemiologic associations of Escherichia coli clonal group A, 1998-2007.

Johnson JR, Menard ME, Lauderdale TL, Kosmidis C, Gordon D, Collignon P, Maslow JN, Andrasević AT, Kuskowski MA; Trans-Global Initiative for Antimicrobial Resistance Analysis Investigators.

Emerg Infect Dis. 2011 Nov;17(11):2001-9. doi: 10.3201/eid1711.110488.

PMID:
22099087
4.

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.

Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C; D:A:D study group.

AIDS. 2010 Jan 28;24(3):427-35. doi: 10.1097/QAD.0b013e328334344e.

PMID:
19910787
5.

5-ALA derivative-mediated photoinactivation of Propionibacterium acnes.

Fotinos N, Mikulic J, Convert M, Campo MA, Piffaretti JC, Gurny R, Lange N.

J Dermatol Sci. 2009 Dec;56(3):214-6. doi: 10.1016/j.jdermsci.2009.07.010. Epub 2009 Aug 25. No abstract available.

PMID:
19709860
6.

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77.

7.

Evidence of horizontal gene transfer between human and animal commensal Escherichia coli strains identified by microarray.

Grasselli E, François P, Gutacker M, Gettler B, Benagli C, Convert M, Boerlin P, Schrenzel J, Piffaretti JC.

FEMS Immunol Med Microbiol. 2008 Aug;53(3):351-8. doi: 10.1111/j.1574-695X.2008.00434.x. Epub 2008 Jun 28.

8.

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.

9.

A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort.

Taffé P, May M; Swiss HIV Cohort Study.

Stat Med. 2008 Oct 15;27(23):4835-53. doi: 10.1002/sim.3294.

PMID:
18444229
10.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292.

11.

Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.

Rudin C, Burri M, Shen Y, Rode R, Nadal D; Pediatric Infectious Disease Group of Switzerland; Swiss Mother and Child HIV Cohort Study (MoCHiV).

Pediatr Infect Dis J. 2008 May;27(5):431-7. doi: 10.1097/INF.0b013e3181646d5a.

PMID:
18382386
12.

Pre-formulation of liposomes against Helicobacter pylori: characterization and interaction with the bacteria.

Bardonnet PL, Faivre V, Boullanger P, Piffaretti JC, Falson F.

Eur J Pharm Biopharm. 2008 Aug;69(3):908-22. doi: 10.1016/j.ejpb.2008.01.018. Epub 2008 Jan 31.

PMID:
18362065
13.

HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.

Weiser B, Philpott S, Klimkait T, Burger H, Kitchen C, Bürgisser P, Gorgievski M, Perrin L, Piffaretti JC, Ledergerber B; Swiss HIV Cohort Study.

AIDS. 2008 Feb 19;22(4):469-79. doi: 10.1097/QAD.0b013e3282f4196c.

PMID:
18301059
14.

Assessment of intraspecific mtDNA variability of European Ixodes ricinus sensu stricto (Acari: Ixodidae).

Casati S, Bernasconi MV, Gern L, Piffaretti JC.

Infect Genet Evol. 2008 Mar;8(2):152-8. doi: 10.1016/j.meegid.2007.11.007. Epub 2007 Dec 4.

PMID:
18206426
15.

Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives.

Fotinos N, Convert M, Piffaretti JC, Gurny R, Lange N.

Antimicrob Agents Chemother. 2008 Apr;52(4):1366-73. doi: 10.1128/AAC.01372-07. Epub 2008 Jan 14.

16.

Comparative genomic hybridization and physiological characterization of environmental isolates indicate that significant (eco-)physiological properties are highly conserved in the species Escherichia coli.

Ihssen J, Grasselli E, Bassin C, François P, Piffaretti JC, Köster W, Schrenzel J, Egli T.

Microbiology. 2007 Jul;153(Pt 7):2052-66.

PMID:
17600050
17.

Distribution and characterization of integrons in Escherichia coli strains of animal and human origin.

Cocchi S, Grasselli E, Gutacker M, Benagli C, Convert M, Piffaretti JC.

FEMS Immunol Med Microbiol. 2007 Jun;50(1):126-32. Epub 2007 Apr 23.

18.
19.

Presence of potentially pathogenic Babesia sp. for human in Ixodes ricinus in Switzerland.

Casati S, Sager H, Gern L, Piffaretti JC.

Ann Agric Environ Med. 2006;13(1):65-70.

20.

Gastroretentive dosage forms: overview and special case of Helicobacter pylori.

Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F.

J Control Release. 2006 Mar 10;111(1-2):1-18. Epub 2006 Jan 5. Review.

PMID:
16403588
Items per page

Supplemental Content

Loading ...
Write to the Help Desk